Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Hazard Ratio

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

Study Designs in Epidemiology

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

Study Design in Statistics

Study Design in Statistics

A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Changing Landscape of Journalology in Medicine.

Seminars in nuclear medicine·2019

Same author

Systematic reviews in restorative dentistry: discussing relevant aspects.

Journal of esthetic and restorative dentistry : official publication of the American Academy of Esthetic Dentistry ... [et al.]·2019

Same author

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2019

Same author

Guidance for reporting outcomes in clinical trials: scoping review protocol.

BMJ open·2019

Same author

Systematic reviews in dentistry: Current status, epidemiological and reporting characteristics.

Journal of dentistry·2019

Same author

Screening for depression in women during pregnancy or the first year postpartum and in the general adult population: a protocol for two systematic reviews to update a guideline of the Canadian Task Force on Preventive Health Care.

Systematic reviews·2019

Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026

Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026

Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026

Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026

Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026

Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026

See all related articles

Search research articles

Related Experiment Videos

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.

Kenneth F Schulz¹, Douglas G Altman, David Moher

¹Family Health International, Research Triangle Park, North Carolina 27709, USA.

Annals of Internal Medicine

|March 26, 2010

Summary

This summary is machine-generated.

The CONSORT statement, a guideline for reporting clinical trials, has been updated to CONSORT 2010. This revision incorporates new evidence to enhance the quality of randomized controlled trial reporting worldwide.

Related Experiment Videos

Area of Science:

Clinical Trials Methodology
Evidence-Based Medicine
Scientific Reporting Standards

Background:

Randomized controlled trials (RCTs) are crucial for medical evidence.
Consistent and transparent reporting of RCTs is essential for validity.
The CONSORT (Consolidated Standards of Reporting Trials) statement addresses reporting quality.

Framework:

CONSORT 2010 is the latest iteration of the reporting guideline.
It provides an updated checklist and explanation for RCT reporting.
The guideline is based on methodological advancements and practical experience.

Implementation:

Researchers worldwide utilize the CONSORT statement.
Adherence to CONSORT 2010 aims to improve the clarity and completeness of trial publications.
Dissemination and adoption of the updated guideline are key.

Implications:

Enhanced reporting facilitates better interpretation of trial results.
Improved transparency supports evidence-based decision-making in healthcare.
CONSORT 2010 contributes to the overall rigor and reliability of clinical research.